TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/8/19 21:32 | 7/3/19 | EIDX | Eidos Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DOT | CEO | P | 26,383 | 29.90 | 0 | 882 | 4 | 24,576 | I | ||||||||||||||
5/29/19 19:15 | 5/24/19 | EIDX | Eidos Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DOT | CEO | P | 28,623 | 25.93 | 0 | 1,104 | 5 | 23,693 | I | ||||||||||||||
6/22/18 18:56 | 6/22/18 | EIDX | Eidos Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DOT | CEO | P.d | 17,000 | 17.00 | 0 | 1,000 | 5 | 19,615 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |